GT200900206A - Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica

Info

Publication number
GT200900206A
GT200900206A GT200900206A GT200900206A GT200900206A GT 200900206 A GT200900206 A GT 200900206A GT 200900206 A GT200900206 A GT 200900206A GT 200900206 A GT200900206 A GT 200900206A GT 200900206 A GT200900206 A GT 200900206A
Authority
GT
Guatemala
Prior art keywords
azabicicloalcano
preparation
composite
pathological
affections
Prior art date
Application number
GT200900206A
Other languages
English (en)
Inventor
Omar Ben Ayad
Odile Leclerc
Alistair Lochead
Mourad Saady
Franck Slowinski
Julien Vache
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38523491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200900206(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200900206A publication Critical patent/GT200900206A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA INVENCIÓN SE REFIERE A LOS COMPUESTOS DERIVADOS DE AZABICICLOALCANO, A SALES DE ADICIÓN DE ESTE COMPUESTO A UN ÁCIDO ACEPTABLE FARMACÉUTICAMENTE, A UN HIDRATO O UN SOLVATO DE ESTE COMPUESTO, PARA LA PREPARACIÓN DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO Y A LA PREVENCIÓN DE LAS ALTERACIONES COGNITIVAS; AFECCIONES DE LOS PROCESOS DE ATENCIÓN, TRASTORNOS DE LAS FUNCIONES EJECUTIVAS ASOCIADAS A LA ENFERMEDAD DE ALZHEIMER, AL ENVEJECIMIENTO PATOLÓGICO O NORMAL, AL SÍNDROME DE PARKINSON, A LA TRISOMÍA 21, A LAS PATOLOGÍAS PSIQUIÁTRICAS, AL TRATAMIENTO Y PREVENCIÓN DE LOS ACCIDENTES VASCULARES CEREBRALES U OTRAS ENFERMEDADES NEUROLÓGICAS O AFECCIONES ANATOMO-HISTO-PATOLÓGICAS ASOCIADAS A ENFERMEDADES NEURODEGENERATIVAS.
GT200900206A 2007-02-09 2009-07-21 Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica GT200900206A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0700940A FR2912404B1 (fr) 2007-02-09 2007-02-09 Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
GT200900206A true GT200900206A (es) 2011-08-18

Family

ID=38523491

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200900206A GT200900206A (es) 2007-02-09 2009-07-21 Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica

Country Status (39)

Country Link
US (2) US8173669B2 (es)
EP (1) EP2118104B1 (es)
JP (1) JP5356257B2 (es)
KR (1) KR101517629B1 (es)
CN (1) CN101605793B (es)
AR (1) AR065248A1 (es)
AU (1) AU2008224785B2 (es)
BR (1) BRPI0806969A2 (es)
CA (1) CA2677713C (es)
CL (1) CL2008000394A1 (es)
CO (1) CO6220857A2 (es)
CR (1) CR10969A (es)
CY (1) CY1113896T1 (es)
DK (1) DK2118104T3 (es)
DO (1) DOP2009000186A (es)
EA (1) EA017802B1 (es)
EC (1) ECSP099568A (es)
ES (1) ES2402328T3 (es)
FR (1) FR2912404B1 (es)
GT (1) GT200900206A (es)
HN (1) HN2009001484A (es)
HR (1) HRP20130279T1 (es)
IL (1) IL199966A (es)
MA (1) MA31233B1 (es)
MX (1) MX2009008492A (es)
MY (1) MY161067A (es)
NI (1) NI200900157A (es)
NZ (1) NZ578673A (es)
PE (1) PE20081664A1 (es)
PL (1) PL2118104T3 (es)
PT (1) PT2118104E (es)
SI (1) SI2118104T1 (es)
SV (1) SV2009003347A (es)
TN (1) TN2009000314A1 (es)
TW (1) TWI395585B (es)
UA (1) UA97833C2 (es)
UY (1) UY30908A1 (es)
WO (1) WO2008110699A2 (es)
ZA (1) ZA200905511B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919490B2 (en) * 2006-10-04 2011-04-05 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
RU2537390C1 (ru) * 2013-07-02 2015-01-10 Федеральное государственное унитарное предприятие "Государственный завод медицинских препаратов" Способ получения 2-экзо-[3'-(6'-хлорпиридил)]-7-азабицикло[2.2.1]-гептана
WO2016015333A1 (en) * 2014-08-01 2016-02-04 F.Hoffmann-La Roche Ag 2-oxa-5-azabicyclo [2.2.1] heptan-3-yl derivatives
CN111777593B (zh) * 2019-04-03 2024-07-23 南京天印健华医药科技有限公司 作为转染期间重排激酶抑制剂的新的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610130D0 (en) * 1986-04-25 1986-05-29 Wellcome Found Pesticidal compounds
AU7474794A (en) * 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
RU2337908C2 (ru) 2003-06-12 2008-11-10 Ново Нордиск А/С Пиридинилкарбаматы в качестве ингибиторов гормон-чувствительной липазы
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.

Also Published As

Publication number Publication date
CN101605793A (zh) 2009-12-16
EP2118104B1 (fr) 2013-01-02
EP2118104A2 (fr) 2009-11-18
AU2008224785B2 (en) 2013-03-14
PL2118104T3 (pl) 2013-05-31
FR2912404B1 (fr) 2009-04-10
HK1139671A1 (en) 2010-09-24
TWI395585B (zh) 2013-05-11
FR2912404A1 (fr) 2008-08-15
PT2118104E (pt) 2013-03-25
AU2008224785A1 (en) 2008-09-18
NI200900157A (es) 2010-07-15
US20100035916A1 (en) 2010-02-11
WO2008110699A3 (fr) 2009-01-15
KR20090106600A (ko) 2009-10-09
DK2118104T3 (da) 2013-04-08
SI2118104T1 (sl) 2013-05-31
TW200838519A (en) 2008-10-01
AR065248A1 (es) 2009-05-27
IL199966A0 (en) 2010-04-15
EA200970745A1 (ru) 2010-02-26
UA97833C2 (ru) 2012-03-26
KR101517629B1 (ko) 2015-05-04
JP5356257B2 (ja) 2013-12-04
MX2009008492A (es) 2009-09-28
CA2677713A1 (fr) 2008-09-18
ZA200905511B (en) 2010-10-27
BRPI0806969A2 (pt) 2014-04-08
MY161067A (en) 2017-04-14
DOP2009000186A (es) 2009-09-15
CY1113896T1 (el) 2016-07-27
MA31233B1 (fr) 2010-03-01
JP2010518053A (ja) 2010-05-27
SV2009003347A (es) 2010-02-01
US8173669B2 (en) 2012-05-08
IL199966A (en) 2014-11-30
NZ578673A (en) 2011-12-22
CN101605793B (zh) 2013-04-24
CR10969A (es) 2009-10-23
EA017802B1 (ru) 2013-03-29
HN2009001484A (es) 2012-01-16
CL2008000394A1 (es) 2008-06-13
CA2677713C (fr) 2015-11-24
CO6220857A2 (es) 2010-11-19
ECSP099568A (es) 2009-09-29
HRP20130279T1 (hr) 2013-04-30
ES2402328T3 (es) 2013-04-30
US8759343B2 (en) 2014-06-24
WO2008110699A2 (fr) 2008-09-18
US20120202807A1 (en) 2012-08-09
UY30908A1 (es) 2008-09-30
PE20081664A1 (es) 2008-12-14
TN2009000314A1 (fr) 2010-12-31

Similar Documents

Publication Publication Date Title
BR112014003225A2 (pt) profármacos de treprostinil ligados a veículo
CO6270332A2 (es) Compuesto de alfa-(n-sulfonamido)acetamida novedoso como inhibidor de produccion de peptido beta amiloide
BR112012013431A8 (pt) composto, composição farmacêutica e seu uso
WO2012080729A3 (en) Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
MX373042B (es) Moleculas para administracion a celulas cancerosas mutantes ros1.
CL2007002641A1 (es) Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
CR20110608A (es) Derivados de 1h-imidazo-[4,5-c]-quinolinona
GT201200250A (es) Ariltriazolonas ligadas a bisarilo y su uso
BRPI0910021A2 (pt) "composto, composição farmacêutica, método para tratar ou atenuar a gravidade de uma doença ou condição responsiva à inibição da atividade jak2 quinas em um paciente, kit para o tratamento de uma doença ou distúrbio responsivo à inibição da jak quinase"
UY32691A (es) Compuestos de 1h-imidazo-[4,5-c]-quinolinona
ECSP088414A (es) Derivados de ácido bifeniloxiacético para el tratamiento de una enfermedad respiratoria
WO2012077932A3 (ko) 신규한 피라졸로 피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
BR112013001753A2 (pt) método para preparar uma composição d einter-alfa-inibidor (iaip) eriquecida de plasma, solução aquosa de iaip, e, método para tratar uma doença ou distúrbio associado com disfunção de iaip e associado com atividadede protease de serina no plasma aumentada.
EA201171087A1 (ru) СПОСОБЫ ВВЕДЕНИЯ (4aR,10aR)-1-н-ПРОПИЛ-1,2,3,4,4a,5,10,10a-ОКТАГИДРОБЕНЗО[g]ХИНОЛИН-6,7-ДИОЛА И РОДСТВЕННЫХ СОЕДИНЕНИЙ ЧЕРЕЗ СЛИЗИСТУЮ ОБОЛОЧКУ ПОЛОСТИ РТА, СЛИЗИСТУЮ ОБОЛОЧКУ НОСА ИЛИ КОЖУ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ИХ ОСНОВЕ
BR112013030264A2 (pt) ácidos acéticos de benzociclohepteno
CL2015001615A1 (es) Una composicion farmaceutica que comprende vortioxetina y donepezilo junto con un excipiente farmaceuticamente aceptable; y su uso para el tratamiento de disfuncion cognitiva, demencia en la enfermedad de alzheimer, disfuncion cognitiva asociada a la depresion y a la esquizofrenia, entre otras enfermedades.
GT200900206A (es) Derivados de azabicicloalcano, su preparacion y su aplicacion en terapeutica
ECSP10010597A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
WO2018071315A3 (en) Piperidine derivatives as liver x receptor beta agonists, compositions, and their use
GT200700097A (es) Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CL2011000520A1 (es) Compuestos derivados de piperazina; uso para preparar un medicamento util para tratar la enfermedad de alzheimaer, un trastorno neurodegenerativo y amiloidosis; metodo de preparacion de compuestos.
WO2010019911A3 (en) 1,4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions
BRPI0607413A2 (pt) composição farmacêutica compreendendo derivados de indolilmaleimida
BRPI0606140A2 (pt) tiazolidinonas, preparação e uso das mesmas como medicamento
BRPI0704074B8 (pt) derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação